Suppr超能文献

微流控技术在药物递送系统中的最新进展:从合成到评估

Recent Development of Drug Delivery Systems through Microfluidics: From Synthesis to Evaluation.

作者信息

Ma Zhiyuan, Li Baicheng, Peng Jie, Gao Dan

机构信息

State Key Laboratory of Chemical Oncogenomics, Guangdong Provincial Key Laboratory of Chemical Biology, Tsinghua Shenzhen International Graduate School, Shenzhen 518055, China.

出版信息

Pharmaceutics. 2022 Feb 17;14(2):434. doi: 10.3390/pharmaceutics14020434.

Abstract

Conventional drug administration usually faces the problems of degradation and rapid excretion when crossing many biological barriers, leading to only a small amount of drugs arriving at pathological sites. Therapeutic drugs delivered by drug delivery systems to the target sites in a controlled manner greatly enhance drug efficacy, bioavailability, and pharmacokinetics with minimal side effects. Due to the distinct advantages of microfluidic techniques, microfluidic setups provide a powerful tool for controlled synthesis of drug delivery systems, precisely controlled drug release, and real-time observation of drug delivery to the desired location at the desired rate. In this review, we present an overview of recent advances in the preparation of nano drug delivery systems and carrier-free drug delivery microfluidic systems, as well as the construction of in vitro models on-a-chip for drug efficiency evaluation of drug delivery systems. We firstly introduce the synthesis of nano drug delivery systems, including liposomes, polymers, and inorganic compounds, followed by detailed descriptions of the carrier-free drug delivery system, including micro-reservoir and microneedle drug delivery systems. Finally, we discuss in vitro models developed on microfluidic devices for the evaluation of drug delivery systems, such as the blood-brain barrier model, vascular model, small intestine model, and so on. The opportunities and challenges of the applications of microfluidic platforms in drug delivery systems, as well as their clinical applications, are also discussed.

摘要

传统的药物给药方式在跨越多种生物屏障时通常会面临降解和快速排泄的问题,导致只有少量药物到达病变部位。通过药物递送系统以可控方式将治疗药物递送至靶位点,可在副作用最小的情况下极大地提高药物疗效、生物利用度和药代动力学。由于微流控技术具有独特优势,微流控装置为药物递送系统的可控合成、精确控制药物释放以及以所需速率实时观察药物向所需位置的递送提供了强大工具。在本综述中,我们概述了纳米药物递送系统和无载体药物递送微流控系统制备方面的最新进展,以及用于评估药物递送系统药物效率的芯片上体外模型的构建。我们首先介绍纳米药物递送系统的合成,包括脂质体、聚合物和无机化合物,随后详细描述无载体药物递送系统,包括微储库和微针药物递送系统。最后,我们讨论在微流控装置上开发的用于评估药物递送系统的体外模型,如血脑屏障模型、血管模型、小肠模型等。还讨论了微流控平台在药物递送系统中的应用机会和挑战及其临床应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b3/8880124/3641c3115337/pharmaceutics-14-00434-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验